Some corners will probably say his aim it to blow-up US healthcare cost (it doesn’t need Soros for that, but anyway)..
November 18th, 2010 · Comments Off on Soros buys big into Dendreon
May 25th, 2009 · Comments Off on What to buy? Gamble on biotech stocks
The regulatory approval process for new drugs is Byzantine, lengthy, and unpredictable. Single stocks are, for outsiders at least (even insiders can be surprised), almost pure bets. But one can still profit from the usual fact that the winnings are often much larger than the possible losses…
May 21st, 2009 · 1 Comment
We’re a bit frustrated, as we the things we follow had quite a run, but now we don’t trust the markets anymore, to be honest. We’re looking for things that could be relatively immune to a market fall. This could be one of them, we already wrote about this company.
April 29th, 2009 · 3 Comments
Now here is real drama, both on the medical front and in the markets. Dendreon (DNDN), you have probably heared about it. The stock was all over the place today as trading was halted after a very short but very steep fall. Then when trading resumed, the stock more than doubled, and when the mist […]